News

Honey Health Secures $7.8M to Revolutionize Healthcare Administration

Honey Health Secures $7.8M to Revolutionize Healthcare Administration

Honey Health Secures $7.8 Million Funding for AI Innovations

The all-in-one AI back office platform is already working with 100+ organizations, saving them millions in administrative overhead.

Honey Health, an innovative AI platform dedicated to streamlining healthcare administration, has successfully raised $7.8 million in a seed funding round that saw contributions from notable investors, including Pelion Ventures. This funding is geared toward advancing their autonomous AI agents that can take on complex administrative workflows directly within healthcare systems, effectively alleviating a significant burden from care teams.

Healthcare organizations are currently grappling with operational challenges that have escalated in recent years. With high turnover rates among non-clinical staff — hovering between 33-40% annually — the pressure on administrative functions has never been more intense. Classic point solutions tend to address only portions of the problem, functioning in isolation and necessitating ongoing oversight. This often leaves healthcare professionals overwhelmed, leading to longer wait times for patients.

"Healthcare organizations are stuck between two ineffective systems: one that relies on fragmented solutions for narrow tasks and another that struggles with staffing issues," remarked Matt Faustman, co-founder and CEO of Honey Health. "We provide a transformative approach: AI agent teams that autonomously undertake full workflows. Our clients come in to find the hard work already done, instead of having to manage new tasks that pile up."

Since its inception, Honey Health has formed partnerships with over 100 medical groups and health systems, demonstrating the tangible value it offers. Reports indicate that clients experience increased annual profits ranging from $50,000 to $65,000 per provider, attributing their success to lowered costs associated with employee turnover and improved operational efficiency. Organizations can now expand their offerings without the need to proportionally increase their back-office staff.

Dr. Kashif Latif, co-owner of AM Endocrinology, expressed his satisfaction stating, "Using Honey Health feels like magic; our back-office functions seamlessly operate within our electronic health record (EHR) system, as if accomplished by a dedicated staff member."

Tailored for mid-market healthcare providers, Honey Health addresses the unique obstacles these organizations must navigate, such as varied EHR systems, limited IT resources, and a disjointed assortment of tools from different vendors. Unlike competitor solutions requiring human intervention or creating additional tasks, Honey's AI agents function much like skilled personnel, engaging with systems independently and executing workflows from start to finish.

Honey Health's current AI agents automate a variety of workflows relevant across many specialties in primary care, including:

  • Data Fetching: Gathers necessary data from external sources such as labs and devices.
  • Note Preparation: Creates ready-to-use patient notes and charts for visits.
  • Order Management: Handles post-visit orders and medicine refills efficiently.
  • Fax Management: Organizes, sorts, and files fax communications while extracting critical information.
  • Prior Authorizations: Oversees the complete authorization procedures.

The unique Loop Framework and Hive Protocol developed by Honey Health facilitates a swift onboarding process for its AI agents, enabling them to adapt to various EHR systems within a month. This understanding of distinct workflows allows them to perform tasks traditionally requiring multiple point solutions, thereby providing flexibility to organizations regardless of their EHR landscape, a crucial benefit for management service organizations (MSOs) and health systems handling various platforms.

Founded by Matt Faustman and Xiao Zhang, both with backgrounds in AI and engineering from LinkedIn, Honey Health stems from personal experiences navigating healthcare bureaucracies. Faustman's own journey with Type 1 Diabetes has further fueled his commitment to enhancing administrative efficiency in healthcare settings.

Tyler Hogge, a partner at Pelion Ventures, emphasized the need for a holistic approach, stating, "The market has grown weary of piecemeal solutions that often complicate matters more than they resolve. The future leans towards integrated platforms that autonomously manage full workflows across multiple systems. Honey embodies this evolution, as it offers more than just task assistance; it completes processes in their entirety. This isn't merely an improvement; it's a transformation of the existing model."

The latest funding round will propel the growth of Honey Health's AI functionalities, bolster its market presence, and expand its workforce to meet escalating demands.

About Honey Health
Honey Health specializes in developing autonomous AI agents that execute essential administrative tasks in healthcare. Their comprehensive back office platform is designed to alleviate the burden of administrative duties that drain time and resources from healthcare institutions. With its team of former LinkedIn AI professionals, Honey Health is already a trusted partner for over 100 medical groups and health systems, helping them enhance efficiency, reduce expenditures, and prioritize patient care.

Frequently Asked Questions

What is Honey Health's primary service offering?

Honey Health offers an AI platform that automates administrative tasks for healthcare organizations, improving efficiency.

How much funding did Honey Health recently raise?

Honey Health raised $7.8 million in seed funding led by Pelion Ventures among others.

Who are the founders of Honey Health?

Honey Health was founded by Matt Faustman and Xiao Zhang, both of whom have backgrounds in AI at LinkedIn.

What benefits do customers see from Honey Health's services?

Customers report annual profit increases between $50,000 and $65,000 per provider, with enhanced operational efficiency.

How does Honey Health's technology integrate with EHR systems?

Honey Health's AI agents can onboard to most EHR systems in under 30 days, adapting to unique workflows.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Admetec Shines Bright with New High-Magnification Headlights

Updated Category News Views 112

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...

Continue Reading
Duke Energy's $500K Push Against South Carolina Hunger

Updated Category News Views 133

A Battle Cry Against Hunger Look, there’s no shortage of firms tossing around cash as PR stunts. But Duke Energy’s latest campaign to tackle hunger in South Carolina right at the root is one effort that seems to echo with a real bang. Coming at us with more than $500,000 in support for nearly 70 organizations across the state, they’re not just talking the talk. This...

Continue Reading
Jungbunzlauer Introduces Johan Westman to Its Board

Updated Category News Views 58

A Strategic Addition to Jungbunzlauer’s Board In what feels like a significant move, Jungbunzlauer has roped in Johan Westman to join its Board of Directors. The man’s got pedigree—a CEO at AAK AB, a Swedish powerhouse dealing in plant-based oils, he's taking a seat at Jungbunzlauer’s table. So, what does this mean for Jungbunzlauer? Well, the potential for...

Continue Reading
Sempra Shines with Robust Q3 2026 Financials

Updated Category News Views 71

Strong Q3 Numbers Set the Scene It’s not every day you see a company cough up numbers that speak volumes. Sempra’s third quarter for 2026 paints a picture of solid performance, boasting earnings of $877 million or $1.34 per diluted share per GAAP standards. That’s an eye-opener compared to the paltry $77 million or $0.12 per share they reported same time last year....

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 62

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Wheels Up Expands Fleet with New Phenom 300E Jets

Updated Category News Views 70

Wheels Up's New Horizons with Phenom 300E Jets Wheels Up Experience Inc. (NYSE: UP) just dropped a bombshell with their plan to purchase six spanking new Phenom 300E jets from Embraer (NYSE: EMBJ). This ain't just another lease agreement; this is their first-ever direct buy from Embraer, and it's set to add some serious flair to their fleet. Setting the Stage for Growth...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 53

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Borussia Dortmund's Q1 2026/2027 Earnings Slip Amid Challenges

Updated Category News Views 49

An Uneven Start to Borussia Dortmund's Financial Year Every finance year kickoff has its tales, and Borussia Dortmund's start for 2026/2027 is no different. The embattled team has been juggling a mixed bag of financial outcomes, darting through initial challenges with a revenue that hovers slightly above the previous year's mark. Revenue crept up to EUR 107.4 million,...

Continue Reading
Drone Composites Market Set for Major Growth by 2031

Updated Category News Views 208

Drone Composites: A Market Poised for Surge Strap in, folks! The drone composites market is gearing up for a wild ride, projected to nearly double from $7.06 billion in 2026 to a whopping $13.59 billion by 2031. That's a solid 14% compound annual growth rate (CAGR) for those keeping score at home. With those numbers, it's no wonder market players are strategizing hard to...

Continue Reading
NIH Seeks AI Solutions for Kidney Disease Breakthroughs

Updated Category News Views 128

A Cosmic Approach to Kidney Disease When you think about celestial wonders captured by telescopes, the last thing that probably comes to mind is kidney disease. Yet, here we are—with the National Institutes of Health (NIH) issuing a peculiar call to arms: apply astronomy's AI methods to unveil patterns in kidney disease data. It's the kind of inspired lunacy that could...

Continue Reading

Top 5 Most Recently Viewed Articles

Christine Russell's Stock Options Move at eGain: What You Should Know

Updated Category News Views 186

Christine Russell's Stock Option Exercise at eGain In a recent filing with the SEC, it was disclosed that Christine Russell, a Board Member at eGain, executed an options exercise that ended up realizing no monetary gain due to the exercise price being set at $0.0. This move raised eyebrows among investors as it was worth 0 shares of the company, painted against eGain's...

Continue Reading
Crown Castle's Q3 2024 Earnings: Growth and Strategic Initiatives

Updated Category News Views 103

Performance Highlights from Crown Castle's Q3 2024 Crown Castle International Corp. (NYSE: CCI) delivered a commendable performance in its third quarter of 2024, showcasing its resilience in the competitive telecommunications sector. The company maintained its full-year outlook for adjusted EBITDA and AFFO while anticipating consolidated organic revenue growth of...

Continue Reading
Alliance Pharma: Significant Recent Activity in Trading

Updated Category News Views 185

Overview of Recent Trading Activity at Alliance Pharma In the landscape of finance, keeping track of significant trading activities is paramount for stakeholders. This is especially true for companies like Alliance Pharma plc, known for their strategic initiatives that directly impact the market. Recently, important disclosures related to trading have captured the...

Continue Reading
Wall Street Surges as Major Corporations Drive Optimism

Updated Category News Views 145

Wall Street's Historic Rally Wall Street has witnessed an impressive rally lately, with significant benchmarks like the S&P 500 and the Nasdaq 100 soaring to all-time highs. This upward momentum is largely attributed to robust corporate earnings, positive economic indicators, and a growing enthusiasm for technology, particularly driven by advancements in artificial...

Continue Reading
AKVA Group ASA: Insights Await as Q3 2025 Results Unveiled

Updated Category News Views 197

Invitation to Q3 2025 Financial Results Presentation AKVA group ASA is excited to extend an invitation for the presentation of its Q3 2025 financial results. This is an excellent opportunity for investors, stakeholders, and anyone interested in understanding the company's performance during this period. Presentation Details The presentation is scheduled for Friday,...

Continue Reading